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RecB and RecA proteins play key roles in the process of DNA recombination in Escherichia coli and both possess DNA unwinding activities which 
can displace short regions of duplex DNA in an ATP-dependent manner in vitro. We have examined the effect of the most abundant DNA adduct 
caused by the chemotherapeutic agent cis-diamminedichloroplatinum(I1) on those activities. For this purpose, we have constructed a partially 
duplex synthetic oligonucleotide containing the intrastrand (GpG) crosslink positioned at a specific site. We report here that both the DNA strand 
separating and DNA-dependent ATPase activities of the RecB protein are inhibited by the d(GpG) cis-DDP adduct. In contrast, neither the 
~winding nor the ATPase activities of RecA protein appear to be perturbed by this lesion. 
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I. I~R~DUCTI~N 
The interaction with DNA of the antitumor drug 
cis-diamminedichloroplatinum(II) (cis-DDP or cis- 
platin) is thought to be responsible for its toxicity and 
mutagenicity ]lJ. Among the DNA adducts formed by 
&DDP, the I,2 intrastrand d(GpG) crosslink is the 
most abundant both in vivo and in vitro [2,3]. This 
lesion represents a strong (although not absolute) im- 
pediment for the in vitro elongation catalyzed by DNA 
and RNA polymerases (4-71, is poorly repaired by puri- 
fied E. coli UvrABC enzyme [S] and appears to be re- 
fractory to repair by human cell extracts [9,10]. 
Previous research on the mechanism of action of cis- 
platin in vitro has mainly investigated the consequences 
of the d(GpG) cis-DDP crosslink on DNA replication, 
transcription or repair [4,7,9]. We thought that it would 
be of interest o examine the effect of this adduct on the 
hehcase activities of two proteins, RecB and RecA, 
which are necessary for recombination of DNA in E. 
coli. Genetic experiments have shown that wild- type 
RecA and RecB proteins participate in cellular proc- 
esses that protect E. coli against he toxic and mutagenic 
effects of cisplatin [1 11. RecA is required for homolo- 
gous recombination and for repair of singfe- stranded 
breaks in DNA 1121, while RecBCD plays a key role in 
the intermolecular events of recombination and in the 
repair of blunt double-stranded breaks [13]. RecA pro- 
tein is able to bypass UV DNA damage and carry out 
strand exchange in vitro 1141. The influence of cisplatin 
lesions on RecA or RecBCD activities is unknown. In 
*Corresponding author. Fax: (33) 61 17 59 94. 
order to investigate the effect of cisplatin on homoio- 
gous DNA repair we have carried out a preliminary 
study on the unwinding activities of RecA and RecB. 
Biochemical and genetic evidences indicate that 
RecBCD enzyme initiates recombination by nicking 
DNA and subsequently unwinding the duplex to pro- 
duce singIe-stranded DNA. RecA protein then pro- 
motes homologous pairing of this ssDNA with duplex 
DNA and DNA strand exchange [I 51. The RecBCD 
protein displays a non-specific nuclease activity. Hence 
we have examined the effect of cisplatin on the unwind- 
ing activity of RecB, the helicase subunit of this enzyme 
11% 
2. MATERIALS AND METHODS 
2.1. Buffers 
RecA unwinding buffer was 30 mM Tris-HCl pH 7.5, 12 mM 
MgC1,, 0.5 mM dithiotheitol, 4% glycerol, 2.5 mM ATP. An ATP 
regeneration system, including 6 mM creatine phosphate and I60 
units/ml creatine phosphokinase, was also present. RecB buffer was 
25 mM MOPS-KOH pH 7, 10 mM Ml& 1 mM dithiotreitol, 100 
m&ml BSA, 2.5 mM ATP. The ATP regeneration system was also 
included. Helicase stop buffer was 100 mM EDTA pH 830% glycerol, 
1% SDS and 0.1% (w/v) Bromophenolblue. 
2.2. Proteins 
RecA was purified to near homogeneity from the ZexA(Def)ArecA 
strain PC1421 [17] harbouring the plasmid pFL352 1181. Purification 
was carried out as previously described [19] except hat bacteria were 
grown to saturation without addition of nalidixic acid. RecA concen- 
tration was determined both by Lowry’s procedure and by absorbance 
at 280 nm using an extinction coefficient of A, = Cl.59 ml. mg-’ . cm-’ 
[ZO]. RecB was purified to near homogeneity as published [21]. The 
concentration of RecB protein was determined by using an extinction 
coefficient of 164,150 M-’ . cm-‘, as calculated from the published 
amino acid sequence [22]. Phosphocreatine kinase (from rabbit mus- 
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cle), and NueIII restriction nuclease were purchased from Boehringer 
Mannheim. T4 polynucleotide kinase was from USB. 
2.3. Chemicals 
cis-Diamminedichloroplatinum(lI), 99.99% pure was purchased 
from Aldrich Chemical Company and solutions were prepared in 5 
mM sodium perchlorate just before use. Creatine phosphate was from 
Boehringer Mannheim. [“P]ATP was purchased from Amersham. 
2.4. DNA substrates: cis-DDP treatment, 5’ end labeling and annealing 
The oligonucleotides shown in Table I (53- and 23-mers) were syn- 
thetised using an Applied Biosystems Synthetiser and purified by 
electrophoresis on a denaturing polyacrylamide gel. Aliquots (30-50 
pg) of the purified 53-mer were resuspended in5 mM Tris-HCl pH 7.5, 
0.5 mM EDTA and incubated with cis-DDP at a molar ratio of 1.5 
Pt/53-mer for 48-72 h at 37’C. At the end of the incubation, the 
53-mer was ethanol- precipitated twice and resuspended in 10 mM 
Tris-HCl pH 7.5, 0.5 mM EDTA. 5’-OH extremities of the purified 
23-mer oligonucleotide were labeled with T4 polynucleotide kinase in 
the buffer supplied by the manufacturer. First, the oligomer (typically 
2000 pmol of 23-mer) was incubated with 200 units of kinase, 50 pmol 
of [“P]ATP and 250 pmol of cold ATP at 37°C for 20 min. Subse- 
quently, in order to phosphorylate the majority of the available 5’-OH 
end, the reaction was chased by addition of 2000 pmol of cold ATP, 
supplemented with 50 more units of kinase and the incubation contin- 
ued for an additional 20 min. The reaction mixture was then heated 
at 70°C for 10 min to inactivate the kinase. Under these conditions, 
we routinely incorporated more than 60% of the labeled [“PIATP, as 
judged by acid precipitation of the product. Annealing of the 53- and 
23-mers was achieved in the following way: a 1.3 molar excess of either 
untreated or cis-DDP treated 53-mer was mixed with the 32P labeled 
23-mer in 50 mM Tris-HCl pH 7.5,10 mM MgCl,, 150 mM NaCl; the 
solution was heated at 85°C for 10 min and slowly cooled to 4°C. The 
annealed material was subsequently ethanol-precipitated and resus- 
pended in 10 mM Tris-HCl pH 7.5, 0.5 mM EDTA. 
2.5. Purification of the cis-DDP treated DNA substrate. 
In a standard preparation of substrate (see Table I), 20 pg of 53123 
duplex DNA were incubated with 800 units of HaeIII restriction 
enzyme in 10 mM Tris-HCI pH 7.5, 10 mM MgC&, 1 mM dithiotreitol 
and 50 mM NaCl for 45 min at 37°C in a final volume of 180~1. Then, 
400 more units of restriction enzyme were added and the incubation 
continued for another 45 min. The reaction was stopped by adding l/4 
of the volume of helicase stop buffer and electrophoresed through a 
20% native polyacrylamide gel at 15 V/cm for 2 h. The band corre- 
sponding to the restriction enzyme resistant material (see Fig. 1) was 
identified by autoradiography, cut out from the gel and eluted at 37°C 
with agitation in 2 ml of 10 mM Tris-HCl pH 7.5, 0.3 M NaCl for at 
least 24 h. The eluted material was ethanol precipitated in presence of 
20 pug of glycogen, centrifuged and resuspended in 10 mM Tris-HCl 
pH 7.5, 0.5 mM EDTA. Routinely, 3&50% of the DNA substrate 
loaded on the gel was recovered. Control experiments howed no 
difference in the capacity of unplatinated substrate to act as a substrate 
for RecB and RecA strand-separating activities when subjected to this 
treatment. At the end of each preparation, the concentration of the 
partially duplex DNA substrates was determined in duplicate by UV 
absorption (A,, = 1 corresponding to 33 @ml). 
2.6. RecB and RecA catalysed unwinding of DNA duplex 
Assays were performed in either RecB or RecA unwinding buffers 
at 30°C for the times, substrates, protein concentrations and volumes 
indicated in the legends of the figures. Reaction buffers always in- 
cluded a 10 times molar excess of unlabeled 23-mer (the same as the 
labeled one) as a trap to prevent he released, labeled oligonucleotide 
from reannealing. Reactions were stopped by the addition of l/4 
volume of helicase stop buffer and the products electrophoresed for 
2 h at 15 V/cm on a 20% native polyacrylamide gel prepared in TBE. 
Gels were dried on DE-81 paper, the radioactive DNA visualized by 
autoradiography, and the autoradiogram used to identify the position 
of both the duplex DNA and the displaced fragment on the gel. The 
corresponding sections of the gel were removed and counted in a 
Beckman scintillation counter. Unwinding activity was expressed as 
a percentage of displaced fragments and values were corrected for 
background by substracting the released fragment obtained in control 
incubations without either protein or ATP. Typically, such back- 
ground represented no more than 15% of the total radioactivity for 
incubation times of 30 min. 
2.7. RecB and RecA ATPase activities 
The DNA-dependent ATPase activities of RecB and RecA proteins 
were measured according to the spectrophotometric method described 
previously [23]. The hydrolysis of ATP is linked to the oxydation of 
NADH by the combined action of pyruvate kinase and L-lactic dehy- 
drogenase in the presence of phosphoenolpyruvate (PEP). Briefly PEP 
is converted to pyruvate by pyruvate kinase when ADP is regenerated 
to ATP. Then pyruvate is transformed to lactate by L-lactic dehydro- 
genase upon oxydation of NADH. The ATPase rate is thus measured 
by following the reduction of absorbance at 340 nm related to the 
oxydation of NADH [24]. The turnover of ATP (k,,,) is equal to the 
ATPase rate divided by the protein concentration. Reaction condi- 
tions for the DNA-dependent ATPase were identical to those for 
DNA unwinding. PEP was 3 mM and pyruvate kinase and lactic 
dehydrogenase were 20 U/ml. 
3. RESULTS 
3.1. Purification of the DNA substrate containing the 
d( GpG) adduct 
A 53-mer oligonucleotide and a complementary 23- 
mer were synthesized for the purpose of this investiga- 
tion (see Table I). The sequence of the 53-mer contained 
a single d(GpG) residue, which is part of the Hue111 
restriction site; no other putative target sequences for 
cis-DDP binding, such as d(ApG) or d(GpXpG) [3], 
were present. Recently the existence of a cis-DDP 
d(GpC) adduct has been reported, but it appeared to be 
a very minor one and the authors attributed its forma- 
tion to an interstrand crosslink 1251. 
Table I 
DNA substrate used in this study 
n 
3’ 
AGAGGAGGAACCGGAGATAGAGG 
5’ 
5’ TTTTTTTTTTTTTTTTCTCCTCCTTGGCCTCTATCTCCTTTTTTTTTTTTTTT 
3’ 
a 
Underlined GG indicate the target sequence forcis-DDP binding. The box shows the 
Hoe111 site present in the template 
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Fig. 1. Structure and purification of the cis-DDP treated DNA sub- 
strate. The purified 53-mer was cis-DDP treated for 72 h at 37°C 
annealed to the complementary 23-mer and digested with Hue111 re- 
striction endonuclease as described in section 2. Lane 1, untreated 
DNA substrate; lane 2, untreated DNA substrate digested with 
HueIII; lanes 3 and 4, as lanes 1 and 2 but with cis-DDP treated DNA; 
lanes 5 to 7, 100 ng of untreated gel-purified DNA substrate incubated 
for 1 h at 37°C with 0, 1 and 5 units of HaeIII, respectively; lanes 8 
to 10, 100 ng of cis-DDP treated gel-purified DNA substrate incubated 
for 1 h at 37°C with 0,l and 5 units of HueIII, respectively. The arrow 
indicates the position of the HaeIII digestion product. 
Fig. 1 shows the different steps in the purification of 
the platinated substrate: the 53 oligomer was treated 
with cis-DDP at a ratio of 1.5 mol of platinum per mol 
of 53-mer for 72 h at 37°C followed by ethanol precip- 
itation and annealing to the radioactive, complemen- 
tary 23-mer. The substrate was then subjected to Hue111 
digestion. It is known that cis-DDP adducts, when 
placed in a restriction site, render the DNA sequence 
resistant to cleavage by the corresponding nuclease 
[4,9]; consequently the majority of the cisplatin treated 
substrate was found to be resistant o Hue111 cleavage, 
under conditions in which almost 100% of the untreated 
substrate was digested (see Fig. 1, lanes l-4). We favour 
the hypothesis that the small quantity of digested mate- 
rial (see lane 4, Fig. 1) is derived from the cleavage of 
molecules containing no lesion; supporting this view is 
the observation that the amount of the digested material 
appeared to increase when the 53 oligomer was treated 
with cisplatin for 48 h instead of 72 (data not shown). 
Kinetic studies of cis-DDP adducts formation per- 
formed on single-stranded DNA exposed to cis-DDP 
for periods up to 26 h, showed that only d(GpG) and 
d(ApG) lesions were formed (see Fig. 3 of ref. [5]). 
The HaeIII-resistant material was then purified as 
described in section 2 and shown to be completely insen- 
sitive to the enzyme cleavage (Fig. 1, lanes 9 and 10). 
Taken together, these experiments trongly suggest hat 
nearly 100% of the cisplatin treated, purified substrate 
molecules, contained a d(GpG) adduct, which is likely 
to be the unique one present. 
3.2. Effect of the d(GpG) adduct on the unwinding activ- 
ity of the E. coli RecB protein 
The RecBCD protein of E. coli is a multifunctional, 
multisubunit enzyme which performs critical functions 
in homologous genetic recombination and is endowed 
with a wide range of activities, such as ATP dependent 
exo- and endonuclease, ATP-dependent helicase and 
DNA-dependent ATPase ([26,27] and references 
therein). 
Of the three subunits, RecB is the sole possessing 
both ATPase and helicase activites and might be consid- 
ered the ‘engine’ of the RecBCD holoenzyme [16]. In 
vitro, nearly all helicases prefer to initiate unwinding of 
duplex DNA possessing a flanking single-stranded 
DNA region [28], therefore we thought that the partially 
duplex oligonucleotide depicted in Table I would be a 
suitable substrate for the protein. At first, we performed 
kinetic experiments to investigate the effect of a d(GpG) 
cis-DDP adduct on strand displacement catalyzed by 
RecB (Fig. 2). In order to obtain a detectable displace- 
ment of the labeled 23-mer, an excess of cold 23-mer 
had to be present in the reaction to prevent immediate 
reannealing of the labeled oligonucleotide. We found 
that a 10 times molar excess of cold 23-mer was neces- 
sary to achieve a complete displacement (data not 
A 
1 2 3 4 5 6 7 8 910111213 14 
100 ‘- B 
Fig. 2. Effect of the d(GpG) cis-DDP adduct on the helicase activity 
of the RecB protein: kinetics of DNA unwinding. Intact or cis-DDP 
treated DNA substrate (77 nM, oligonucleotide) was incubated at 
30°C with 25 nM RecB protein in a total volume of 40 ~1 containing 
RecB protein buffer and a tenfold excess of unlabeled 23-mer. At times 
indicated, 5 ~1 aliquots were taken and the percentage of 23-mer 
released determined by polyacrylamide gel electrophoresis as de- 
scribed in section 2. (A) Autoradiogram showing the reaction prod- 
ucts: lanes 1 to 7, untreated DNA substrate; lanes 8 to 14, cis-DDP 
treated DNA substrate. Lanes 1 to 6 and 8 to 13: 0, 2, 5, 10, 20 and 
40 minutes time points, respectively. Lanes 7 and 14: heat denatured 
substrates. (B) Quantification of the data shown in (A): sections corre- 
sponding to the radioactive bands shown in Fig. 2A were excised from 
the gel and processed as described in section 2. The amount of dis- 
placed 23-mer was calculated as a percentage of the heat denatured 
control. Calculations made as percentage of the total radioactivity for 
each time point gave comparable values. Untreated DNA, filled cir- 
cles; cis-DDP treated DNA, open circles. 
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Fig. 3. Effect of the d(GpG) cis-DDP adduct on the helicase activity 
of the RecB protein: protein titration. Intact or cis-DDP treated DNA 
substrate (160 nM, oligonucleotide) was incubated at 30°C with given 
concentrations of RecB protein in RecB protein buffer and a tenfold 
excess of unlabeled 23-mer. After a 5 min incubation, the reactions 
were stopped and the percentage of displaced 23-mer determined as 
described in the legend to Fig. 2. Untreated DNA, filled circles; cis- 
DDP treated DNA, open circles. 
shown); the same requirement was reported for experi- 
ments investigating the unwinding of partially duplex 
oligonucleotides by other prokaryotic helicases [29,30]. 
As can be seen from Fig. 2A and B, the d(GpG) cis- 
DDP lesion decreased the unwinding activity of RecB. 
The pattern of inhibition shown in Fig. 2 has been 
reproduced with four different preparations of the par- 
tially duplex substrate. The mean of three independent 
time course experiments, performed with one substrate 
preparation, led us to estimate that RecB activity is 
reduced by 40% under these experimental conditions. 
Addition of fresh enzyme after 15 min reaction did not 
change the reaction rate on the platinated substrate. On 
the other hand, addition of fresh substrate during the 
course of the reaction led to increased strand displace- 
ment, indicating that the enzyme remains active (data 
not shown). 
Finally, we investigated the effect of varying the con- 
centration of RecB protein on its capacity to unwind 
cis-DDP treated or untreated substrate. The result 
shown in Fig. 3 indicates that the extent of inhibition 
of the RecB activity by the d(GpG) adduct remained 
roughly constant throughout a ten fold range variation 
of the protein concentration. Even at an excess molar 
ratio of protein over substrate comparable to conditions 
used for RecA (160 nM RecB for 20 nM substrate), we 
observed about 40% inhibition of RecB unwinding ac- 
tivity by the lesion (data not shown). 
3.3. Effect of the d(GpG) adduct on the unwinding activ- 
ity of the E. coli RecA protein 
RecA protein plays a key role in the recombination 
process of E. coli and catalyzes DNA strand exchange 
in vitro [31]. RecA has been shown to possess a DNA 
unwinding activity, although limited to the displace- 
ment of short duplexes [32]. Accordingly, we found here 
that RecA could displace, in an ATP-dependent man- 
ner, the 23 oligonucleotides from the duplex DNA sub- 
strate (Fig. 4) although it did so less efficiently than 
RecB under our experimental conditions. In fact, 
roughly 700 nM RecA protein versus 25 nM RecB pro- 
tein was required to displace the same amount of sub- 
strate (compare Figs. 2 and 4), suggesting that RecA 
protein is required in stoichiometric amounts. As for 
RecB, reactions were run in presence of 10 molar excess 
of cold 23-mer. Kinetic experiments aimed at investigat- 
ing the effect of the d(GpG) cis-DDP lesion on strand 
unwinding catalysed by RecA revealed no effect of the 
adduct (Fig. 4), in contrast to results for RecB. Several 
experiments, performed with three different prepara- 
tions of the partially duplex substrate, gave results com- 
parable to the one shown in Fig. 4. As in the case of 
RecB, we then investigated the effect of varying concen- 
tration of RecA protein on its capacity to unwind un- 
A 
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Fig. 4. Effect of d(GpG) cis-DDP adduct on the helicase activity of 
the RecA protein: kinetics of DNA unwinding. Intact or cis-DDP 
treated DNA substrate (110 nM, oligonucleotide) was incubated at 
30°C with 750 nM RecA protein in a total volume of 35 ~1 containing 
RecA protein buffer and a tenfold excess of unlabeled 23-mer. At the 
times indicated, 5 ~1 aliquots were taken and the percentage of 23-mer 
released determined by polyacrylamide gel electrophoresis as de- 
scribed in section 2. (A) Autoradiogram showing the reaction prod- 
ucts: lanes 1 to 6, untreated DNA substrate; lanes 7 to 12, cis-DDP 
treated DNA substrate. Lanes 2 to 6 and 7 to 11: 0, 5, 10, 15 and 20 
min time points, respectively. Lanes 1 and 12: heat-denatured sub- 
strates. (B) Quantification of the data shown in (A): section corre- 
sponding to the radioactive bands shown in Fig. 4(A) were excised 
from the gel and processed as described in section 2. The amount of 
the displaced 23-mer was calculated as described in Fig. 2B. Untreated 
DNA, filled triangles; cis-DDP treated DNA, open triangles. 
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Table II 
Turnover number of ATP 
a b C 
RecB 800 min-’ 2870 min-’ 1790 min-’ 
RecA 20 min-’ 27 min-’ 25.5 min-’ 
The turnover was measured as described in Section 2 using either 14.2 
nM RecB or 530 nM RecA and (a) 600 nM 23-mer alone (b) 600 nM 
23-mer plus 60 nM intact duplex 53/23 mers (c) 600 nM 23-mer plus 
60 nM duplex 53/23-mers containing the d(GpG) cisplatin adduct. 
Values represent he average of three independent experiments with 
RecB and four independent experiments with RecA. No hydrolysis 
was detected in absence of DNA. 
treated or cisplatin treated substrate and found that the 
d(GpG) lesion did not affect this activity throughout a 
tenfold range of the protein concentration (Fig. 5). 
3.4. Effect of the d(GpG) adduct on the ATPase activity 
of the RecB and RecA proteins 
The DNA unwinding activity of both RecB and RecA 
is dependent upon ATP hydrolysis [16,32]. Therefore, 
we have compared, under the same experimental condi- 
tions used to monitor DNA strand separation, the ex- 
tent of ATP hydrolysis by RecB and RecA in presence 
of substrate that was either intact or bearing the 
d(GpG) cis-DDP adduct. As can be seen in Table II, 
ATP hydrolysis by RecB is significantly reduced in pres- 
ence of the d(GpG) cis-DDP lesion, while RecA ATPase 
activity remained essentially unchanged (compare col- 
umns b and c). Two comments hould be made concern- 
ing the data shown in Table II. First, the levels of ATP- 
ase activity found, which are very similar to the ones 
reported in literature for both proteins [16,31], are much 
higher for RecB than for RecA. Second, this activity is 
REC A (“M) 
Fig. 5. Effect of the d(GpG) c&DDP adduct on the helicase activity 
of the RecA protein: protein titration. Intact or cis-DDP treated DNA 
substrate (160 nM, oligonucleotide) was incubated at 30°C with given 
concentrations of RecA protein buffer and ten-fold excess of unla- 
beled 23-mer. After a 10 min incubation, the reactions were stopped 
and the percentage of displaced 23-mer determined as described in the 
legend to Fig. 2. Untreated DNA, filled triangles; cis-DDP treated 
DNA, open triangles. 
readily detectable when the excess of cold 23-mer, nor- 
mally used as trap in the unwinding reaction, is present 
as sole substrate (see column a of Table II). Neverthe- 
less, addition of partially duplex 53/23-mers DNA, at 
one tenth level of the 23-mer alone, increases the ATP 
hydrolysis by the RecB enzyme of nearly a factor five, 
indicating its strong preference for this substrate as 
ATPase cofactor. This finding is in agreement with pre- 
vious work, showing a dramatic increase in RecB cat- 
alysed ATP hydrolysis as a function of DNA length (see 
Fig. 6 of ref. [21]). In summary, the ATPase data pre- 
sented indicate that ATP hydrolysis by RecB in pres- 
ence of a substrate containing a d(GpG) adduct was 
reduced by about 40% when compared to hydrolysis in 
the presence of the same amount of intact substrate. 
This reduction is consistent with the unwinding activity 
of the protein measured under the same experimental 
conditions. 
4. DISCUSSION 
Drug induced damage in DNA has been shown to 
severely inhibit the action of several enzymes involved 
in DNA metabolism and the toxicity and mutagenicity 
of a given lesion could be modulated by the extent of 
such inhibition. The antitumoral drug cis-diamminedi- 
chloroplatinum(II), after initial binding to a guanine 
reacts with another purine base to form bifunctionnal 
intra and interstrand lesions [33,34]. Over the past 
years, a number of laboratories have studied the effect 
of cis-DDP lesions on DNA replication and transcrip- 
tion. Some of those studies have been performed on 
templates containing different types of intrastrand ad- 
ducts, such as those implicating d(GpG), d(ApG) or 
d(GpXpG) residues [35,36]. In other instances, sub- 
strates containing well defined adducts were used to 
explore the toxic and mutagenic potential of a given 
lesion. Along these lines, the role in DNA replication, 
transcription and repair of the most abundant cisplatin 
lesion, the d(GpG) adduct, has been recently investi- 
gated [4,6,7,9]. In addition to DNA and RNA polym- 
erases, DNA lesions might affect other key enzymes of 
the DNA metabolism, such as DNA helicases, which 
play a fundamental role not only in DNA replication 
and transcription, but also in DNA repair and recombi- 
nation [28]. Indeed, the activity of helicases associated 
either with the replicative E. coli protein Rep and to the 
T4 phage replicative protein Dda or with the E. co/i 
repair UvrD, have been shown to be inhibited in vitro 
by the antitumor agent CC-1065 [29,30]. In addition, it 
has been recently reported that the strand displacement 
activities of the Rad3 and helicaseI1 proteins, which are 
absolutely required for yeast and E. coli DNA excision 
repair, are inhibited by the whole cis-DDP intrastrand 
lesions, although to a different extent [37,38]. 
We have investigated here the effect of the d(GpG) 
adduct on the strand separating activity associated with 
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RecB and RecA proteins, two essential constituents of 
the process of homologous recombination in E. co&. 
The RecB protein is a subunit of the RecBCD holoen- 
zyme, a multisubunit complex that is involved in path- 
ways of homologous recombination and DNA repair. 
The RecBCD holoenzyme can generate single-stranded 
regions of DNA by virtue of its helicase activity. These 
single-stranded DNA tails are then used by RecA pro- 
tein to promote homologous pairing between comple- 
mentary strands and strand-exchange [27]. Of RecBCD 
enzyme subunits, only the RecB protein possesses 
DNA-dependent ATPase and helicase activities [ 161. 
The RecA protein also possesses the ability to unwind 
short regions of duplex DNA in an ATP-dependent 
manner. It has been postulated that this activity is re- 
quired to disrupt regions of secondary structure in sin- 
gle-stranded stretches of DNA, to facilitate the forma- 
tion of heteroduplex DNA during strand exchange 
[32,39]. 
In vitro, most helicases require single-stranded DNA 
loading sites 1281. For this reason, we constructed the 
partial DNA duplex depicted in Fig. 1. This DNA sub- 
strate contains 23 base pairs of duplex DNA with both 
5’ and 3’ single-stranded DNA tails, as well as single, 
specific d(GpG) c&DDP lesion. Both the RecB and 
RecA proteins could efficiently displace the 23-mer 
when annealed to the untreated 53-mer but, while RecA 
protein could also displace the 23-mer when annealed 
to the 53-mer containing the d(GpG) cis-DDP intra- 
strand crosslink, the RecB protein appeared to be inhib- 
ited by this lesion (see Figs. 2 to 5). This inhibition was 
consistently observed thoughout a serie of kinetic exper- 
iments and by varying the concentrations of the protein 
in the assay. We estimated that the presence of the 
cis-DDP adduct blocked 40% of the unwinding capacity 
of RecB. This degree of inhibition can be compared to 
the one observed for yeast Rad3 and E. coli helicase II 
1381. In fact, the authors calculated that it required one 
cisplatin adductll25 bases in the case of Rad3 protein 
and one adduct/ bases in the case of DNA helicaseI1 
to reduce DNA helicase activity to 37%. 
Both RecB and RecA require DNA-dependent ATP 
hydrolysis in order to express their helicase activity 
[X6,32]. We therefore measured ATP hydrolysis during 
the in vitro strand displacement reaction by these pro- 
teins in the same experimental conditions as the gel 
experiments. As shown in Table II, ATPase activity of 
RecB appeared to be much greater than RecA. Further- 
more, ATP hydrolysis by RecB but not RecA decreased 
during its attempt to unwind the platinated substrate. 
ATP hydrolysis and strand separating activity of RecB 
protein were inhibited by about 40% in the presence of 
platinated substrate. 
Although both proteins could displace a substantial 
part of the short duplex from the substrate, RecB was 
more efficient than RecA. Since the reactions reported 
here were performed in presence of an excess of cold 
94 
23-mer, which was used as trap to prevent reannealing 
of the displaced strand, we asked the question of 
whether the relative inefficiency of RecA could be attri- 
buted to an increased, unproductive binding of RecA to 
the 23-mer which would sequester part of the protein. 
To answer this question we carried out a gel retardation 
experiment [40] using RecB and RecA proteins and 0.6 
PM of labeled 23-mer as sole substrate. Even at concen- 
trations of 0.1 FM for RecB and 2 FM for RecA no 
retardation effect was observed. Under the same exper- 
imental conditions, 2 ,uM E. coli single stranded binding 
protein (SSB) provoked a dramatic shift of the 23-mer 
(data not shown). Hence, the excess 23-mer did not 
seem to unproductively bind RecA, and the difference 
observed in the unwinding and ATPase activities might 
reflect some intrinsec properties of the proteins or their 
differential binding to the partially duplex substrate. In 
this respect, it is interesting to note that RecA forms 
filaments along single-stranded DNA [31], 
What could then be the mechanism of RecB inhibi- 
tion by the d(GpG) cis-DDP adduct? In the case of the 
yeast Rad3 helicase it had been shown that a variety of 
DNA lesions, including cisplatin intrastrand adducts, 
formed a stable protein-damaged DNA complex, as a 
consequence of which the protein remained sequestered 
at the lesion encountered uring its translocation along 
the substrate [37]. The same qualitative effect has been 
observed with helicaseI1, although the extent of seques- 
tration is much less pronounced [38]. To test if this 
hypothesis can be extented to the unwinding activity 
associated to RecB, we performed four experiments in 
which the protein was allowed to act on either intact or 
damaged substrates for times varying from 10 to 20 
minutes, then intact ‘reporter’ substrate was added and 
the capacity of the protein to displace the newly added 
substrate was kinetically mesured. We observed no sig- 
nificant differences in the capacity of RecB, ‘preincu- 
bated’ with substrates intact or containing the d(GpG) 
cis-DDP adduct, to unwind the reporter substrate (data 
not shown). Consequently, the RecB protein could 
freely dissociate from either DNA substrate to initiate 
DNA unwinding on the challenge DNA. Thus, it is 
possible that the RecB protein simply stalls at the lesion 
as it translocates along the DNA and then dissociates 
from the substrate. Alternatively, considering that the 
d(GpG) cis-DDP cross link induces a high degree of 
DNA bending [41,42], the inhibition of the RecB pro- 
tein-mediated DNA unwinding may be due to the re- 
duced capacity for it to interact with curved DNA. 
In conclusion, we have presented evidence that the 
d(GpG) cis-DDP adduct significantly inhibits the DNA 
helicase and DNA-dependent ATPase activities of the 
RecB protein, while it had no effect on the same activi- 
ties associated with the RecA protein. The insensitivity 
of the RecA protein associated DNA unwinding activity 
towards this lesion is perhaps no surprise, since it is 
known that RecA protein promoted strand exchange 
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can bypass lesions in the DNA including thymine 
dimers, as well as mismatches [14]. It will now be inter- 
esting to see if the d(GpG) c&DDP adduct also signif- 
icantly inhibits the helicase activity of the RecBCD 
holoenzyme, since association of the RecB protein with 
the other subunits results in a complex possessing a 
highly processive DNA helicase coupled to exo- and 
endonuclease activities [43]. The RecBCD complex 
pauses and nicks at a specific DNA sequence, known as 
the recombinational hotspot Chi [27, 441. It has been 
proposed that C&specific cleavage is a result of non- 
specific nuclease activity of the enzyme that has been 
sequestered at the site and that any pause of the 
RecBCD enzyme during its translocation on DNA in- 
creases the probability of a nucleolitic event [27 and 
references therein]. If this hypothesis is correct, inhibi- 
tion of RecBCD helicase activity by cisplatin, as sug- 
gested by our results with RecB, could lead to unsched- 
uled DNA cleavage. Further experiments are needed to 
test this putative genotoxic effect of cisplatin on homol- 
ogous recombination. 
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